Wednesday, July 8, 2026

biotech · Major Depressive Disorder · Alzheimer's Disease · NMRA

Neumora Therapeutics

Neumora Therapeutics drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

copenhagen, DK HQ
18 Employees
Public company Type
NMRA · NYSE Ticker
Company details
Intelligence · Drug Pipeline

Neumora Therapeutics pipeline

Portfolio lens on 2 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.

Neumora Therapeutics drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

Drug portfolio

2 compounds
  1. Development asset linked to Neumora Therapeutics in public FDA and regional records.

  2. Development asset linked to Neumora Therapeutics in public FDA and regional records.